Charles River Laboratories | CRL - نسبة السعر إلى الأرباح

سعر السهم
166.79
التغيير اليومي
-4.44 -2.59%
شهريا
4.43%
سنويا
42.20%
Q2 التوقعات
166.17




Pe تغيير تاريخ
Agilent 25.04 2.13 2025-12
Align Technology 19.74 1.58 2025-12
Bio-Rad Laboratories 16.42 17.1 2025-09
Bruker 81.36 60.11 2025-12
Cardinal Health 24.53 4.66 2025-12
Charles River Laboratories 43.58 0.86 2025-12
Cigna 10.56 0.76 2025-12
CVS Health 14.39 2.15 2025-12
Danaher 29.29 10.39 2026-03
Dentsply International 29.99 15.81 2025-12
Elevance Health 12.4 0.98 2026-03
Galapagos 3.14 50.78 2025-12
Humana 26.05 7.23 2025-12
Illumina 30.38 15.53 2025-12
Incyte 14.84 2.79 2025-12
Intrexon 7.54 221.44 2021-12
IQVIA Holdings 26.59 2.03 2025-12
Laboratory Of America 20.86 10.79 2025-12
Lonza 34.34 2.58 2025-12
McKesson 23.85 0.07 2025-12
Merck 20.56 7.18 2025-12
Mettler Toledo International 32.41 2.38 2025-12
Novartis 20.17 2.32 2026-03
Pfizer 14.48 5.18 2025-12
Quest Diagnostics 22.4 2.63 2026-03
Revvity 49.87 16.58 2025-12
Thermo Fisher Scientific 27.71 3.29 2026-03
United Therapeutics 17.32 1.62 2025-12
UnitedHealth 15.29 4.5 2026-03
Veradigm 11.15 4.63 2022-09
Waters 35.29 8.46 2025-12
West Pharmaceutical Services 31.99 5.76 2026-03